This policy briefing describes the recent cereulide toxin formula contamination and recall event in the UK, including the scale of the incident, the official public health response, and the effects on formula supply chains and market stability. It considers the wider implications for infant food safety and infant food security, and makes recommendations for government.

The recalls followed the detection of cereulide, a bacterial toxin produced by Bacillus cereus, in a range
of commercial milk formula products, including many infant formulas. Cereulide contamination can cause rapid-onset gastrointestinal illness and dehydration*, which can become life-threatening in young infants if not recognised and treated promptly. Its detection in formula milks available in the UK retail chain exposed important weaknesses in the safety and security systems governing infant foods. The detection of cereulide toxin in formula milks exposed important weaknesses in the safety and security systems governing infant foods.

Although the UK public health assessment now claims that the likelihood of infant exposure to cereulide toxin is low, evidence suggests that contaminated products may have been on the UK market from May 20251 until the first Food Standards Agency alert on 5 January 2026.2 This raises questions about the adequacy of existing regulatory oversight, surveillance and incident response arrangements.

More than 60 formula milk batches were implicated in UK recalls,3 and 61 reports of symptoms consistent with cereulide poisoning were identified among children who had consumed affected products across the UK and Crown Dependencies.4 The true number of affected infants is likely to be higher, and the incident remains under investigation.

* Cereulide poisoning typically presents with nausea, vomiting, diarrhoea and abdominal cramps occurring shortly after consumption. See UK Health Security Agency, “HPR Volume 20 Issue 1: News (29 January
and 5 February 2026),” GOV.UK, 5 March 2026, https:// www.gov.uk/government/publications/health-protection- report-volume-20-2026/hpr-volume-20-issue-1-news-29- january-2026.january-2026.

The incident also highlighted a structural vulnerability
in the manufacture and distribution of infant formula, which is currently the only recommended alternative to breastmilk during the first year of life. It highlights how ingredient sourcing, market concentration and globalised production can turn a contamination event into both

a public health risk and a supply risk, endangering infant health and disrupting access to a product that the majority of UK infants rely on as their primary food source in the first six months of life.

Although the total volume of recalled formula milk has not been made public, the affected brands together accounted for approximately 85% of the UK commercial milk formula market.5 At the peak of the disruption, 28.4% of formula milk products were out of stock,6 and some products saw sharp retail price increases.7 These impacts demonstrate the close relationship between formula safety, affordability and availability. Neither infant formula supply or breastfeeding support are currently included in UK food security assessments, limiting preparedness for future disruption.8

Public health communications during the recall were also insufficient. Families were not consistently provided with clear, consolidated and practical guidance on how to maintain safe and appropriate infant feeding practices while avoiding affected formula milk products.